RecruitingNot ApplicableNCT06387017

Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway


Sponsor

Assistance Publique Hopitaux De Marseille

Enrollment

750 participants

Start Date

Apr 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Interventional study with minimal risks and constraints, with evaluation of the incidence of lung cancers by low-dose thoracic CT scan without injection of contrast medium, of the immunological, inflammatory and metabolic blood profile and of the microbiota; systematic proposal of smoking cessation for active smokers or assistance in maintaining cessation.


Eligibility

Min Age: 45 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether certain markers in the blood can help identify lung cancer early in people who are heavy smokers and also have artery disease (blockages in blood vessels). Early detection through blood tests could allow treatment when the cancer is most curable. **You may be eligible if...** - You are between 45 and 75 years old (or up to 80 by some criteria) - You are a current or former smoker with at least 10 years of daily smoking - You have artery disease (heart, legs, or other vessels), a high coronary calcium score, or qualify for lung cancer screening based on smoking history - You are in medical follow-up for a smoking-related condition **You may NOT be eligible if...** - You have been diagnosed with cancer in the last 5 years (with some exceptions) - You have symptoms suggesting lung cancer (unexplained weight loss over 7 kg, or coughing up blood) - You have known lung nodules requiring specialist monitoring - You have pulmonary fibrosis or pulmonary hypertension - You have severe heart or breathing problems at rest - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTblood sampling

blood collection

DIAGNOSTIC_TESTstool collection

stool collection

RADIATIONlow dose CT scan

low dose CT scan evaluation


Locations(1)

Assistance Publique Hopitaux de Marseille

Marseille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06387017


Related Trials